October 26, 2020
Source: Press Release, Prague (CZ)
SOTIO, a clinical stage immuno-oncology company owned by PPF Group, today announced that Jens Hennecke, chief business officer of SOTIO, is presenting on our lead programs at BIO-Europe Digital being held on October 26-29, 2020. The presentation will be made available on demand on the Bio Europe website and accessible to attendees registered for the event.
The 26th annual BIO-Europe global life sciences partnering event will be held October 26–29 in a fully digital format. It includes on-demand early access to the company pitches, program sessions, and sponsor and showcase company content up to five weeks prior to the live event for the best possible networking and meeting decisions once partnering begins.
About BIO-EUROPE
For more than 25 years BIO-Europe has played an instrumental role in bringing biopharma and investment leaders together, to facilitate innovation and medical breakthroughs. The event is expected to bring together over 3,000 executives from more than 1,400 life sciences companies spanning an estimated 50+ countries. Without the need to travel, more delegates can participate worldwide. With program content in business development, therapeutic areas, startup innovations, digital health, and more available on demand beforehand as well as live sessions during the conference, there is more opportunity to watch panels and pitches without interrupting scheduled one-to-one meetings.
